Observational Study for Inflammatory Bowel Disease
This is an observational study for people with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. Researchers want to better understand IBD over time by collecting information and samples from participants. They are looking for new markers (biomarkers) that can show how active the disease is or how well treatments are working. The study is also looking at how immune cells, diet, and genes might affect IBD. You can join if you are between 18 and 85 years old and have IBD. The current recruitment status is unclear.
- Study design
- This is an observational study aiming to enroll 100 participants with Inflammatory Bowel Disease and their healthy adult family members.
- What's involved
- Affected participants will have clinic visits every 6 months for at least 3 years, providing clinical data and specimens.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for at least 3 years to collect clinical data and specimens.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kristi C Briggs, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- To collect longitudinal clinical data and specimens, with the goal of identifying novel biomarkers correlating with disease activity or response to therapy3 years